[Position of diuretics in the treatment of heart failure in light of current guidelines]

Area of Science:

• Cardiology
• Pharmacology

Background:

• Diuretics are the longest-used drugs in heart failure (HF) management after digoxin.
• Their use is attributed to managing sodium retention and extracellular fluid volume expansion secondary to neurohormonal and hemodynamic disturbances in HF.
• Discontinuation or inadequate dosing of diuretics can precipitate acute decompensated heart failure.

Purpose of the Study:

• To review the role and effectiveness of diuretics in heart failure management.
• To highlight the evidence base, or lack thereof, for current diuretic indications in HF.
• To emphasize the symptomatic benefits of diuretics in HF patients with fluid retention.

Main Methods:

• Review of existing literature on diuretic use in heart failure.
• Analysis of clinical trial data and expert opinion regarding diuretic efficacy.
• Examination of the impact of diuretics on heart failure exacerbations and symptoms.

Main Results:

• Diuretics effectively alleviate symptoms of fluid overload, such as shortness of breath and edema, in heart failure patients.
• Evidence supporting the effectiveness of most diuretics in clinical trials is limited, with indications often based on expert consensus.
• The impact of diuretics on morbidity and mortality in heart failure patients has not been extensively studied.

Conclusions:

• Diuretics remain a cornerstone for symptomatic management of fluid retention in heart failure, irrespective of left ventricular ejection fraction.
• Current indications for diuretic use in heart failure are largely based on expert opinion rather than robust clinical trial data.
• Further research is needed to elucidate the effects of diuretics on long-term outcomes, including morbidity and mortality, in heart failure patients.